LP265334-5
Tildipirosin
Active
Description
Veterinary Medicine: Tildipirosin is a macrolide antibiotic used in the treatment and prevention of bovine respiratory disease (BRD) that is administered as a single subcutaneous dose. The antibiotic primarily targets Mannheimia haemolytica, Pasteurella multocida and Histophilus somni bacteria which are the three most common pathogens found in BRD. Tildipirosin achieves a much higher concentration in lung tissue and bronchial fluid for an extended period of time compared to plasma. The lung tissue to plasma concentration ratio peaks close to 200, while bronchial fluid to plasma peaks at around 70. The terminal half-life in plasma, lung tissue, and bronchial fluid are 9, 10, and 11 days, respectively. PMID: 22188102 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Tildipirosin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2017-12-21
- Construct for LOINC Short Name
- Tildipirosin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP265334-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| it-IT | Italian (Italy) | Tildipirosina |
| zh-CN | Chinese (China) | 泰地罗新 Synonyms: 20-Deoxo-23-deoxy-5-O-[3,6-dideoxy-3-(dimethylamino)-beta-D-glucopyranosyl]-20,23-di-1-piperidinyltylonolide; |
| es-ES | Spanish (Spain) | Tildipirosina |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright